Medulloblastoma, a cancer that primarily affects children, is the most common malignant brain tumor in this age group. Particularly for the group 3/4 subtypes of medulloblastoma, treatment remains a major challenge. These tumors are notorious for their complexity and the difficulty in predicting how they will behave, making it difficult to provide tailored treatments …
Oncogene aberrations drive medulloblastoma progression, not initiation
Share.
